UBC has managed expanded access programs (EAPs), also known as compassionate use programs, to treat many conditions, including cancer, HIV, Alzheimer’s disease, psychosis and cystic fibrosis. We’ve gained critical insights into what processes work best for enrolling patients and capturing data quickly and efficiently. We’ve learned that teams supporting these programs should excel at three core competencies: speed, flexibility and collaboration.
Compassionate use programs provide access to investigational products on unsolicited physician requests for patients with serious or immediately life-threatening conditions. These patients either have limited treatment options or have exhausted all other standard therapies.